FMOD and breast cancer: Thus our present study identifies the molecular and cellular mechanisms by which FMOD expression and BCCMI are regulated, and through which Aspirin exerts anti-metastatic effects on breast cancer by downregulating the HDAC6-β-catenin-FMOD-ERK axis.